
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is a leading medical technology company with a strong presence in the global market for silicone-filled breast and body-shaping implants. With above-average revenue growth, an attractive gross margin, innovative R&D, and numerous market-expanding catalysts, the company has a promising outlook. Additionally, its recent positive financial results and increasing adoption of its minimally invasive platforms, Preservé and Mia, by surgeons in the U.S. and other markets further support our positive outlook.
Bears say
Establishment Labs Hldgs is facing potential risks in terms of competition and the potential for economic recession. While the company has multiple pipeline initiatives and innovative R&D, there is an uncertainty with the regulatory pathway for these products. Furthermore, the company's valuation is at a premium, and risks include potential funding needs and unsuccessful launch of pipeline products.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares